SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EARNINGS FLASH L impact

Apimeds Pharmaceuticals US Reports Third Quarter 2026 Results, Delivers First Operating Revenue from Technology Services

Quarterly revenue of $2.89 million and operating income of $2.0 million as the company completes its

APUS

Related stories